Protein tyrosine kinases: structure, substrate specificity, and drug discovery.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 9817025)

Published in Biopolymers on January 01, 1998

Authors

F A al-Obeidi1, J J Wu, K S Lam

Author Affiliations

1: Selectide Corporation, A Subsidiary of Hoechst Marion Roussel, Inc., Tucson, AZ 85737, USA.

Articles citing this

Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J Exp Med (2000) 1.45

Hydrophobic Core Variations Provide a Structural Framework for Tyrosine Kinase Evolution and Functional Specialization. PLoS Genet (2016) 1.43

Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38

Rapid characterization of green fluorescent protein fusion proteins on the molecular and cellular level by fluorescence correlation microscopy. Proc Natl Acad Sci U S A (1999) 1.34

Expression of DFak56, a Drosophila homolog of vertebrate focal adhesion kinase, supports a role in cell migration in vivo. Proc Natl Acad Sci U S A (1999) 0.97

Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPbeta) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J (2002) 0.95

Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads. Anal Biochem (2005) 0.86

Substrate activity screening with kinases: discovery of small-molecule substrate-competitive c-Src inhibitors. Angew Chem Int Ed Engl (2014) 0.82

DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells. Biochem J (2000) 0.82

Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges. ACS Chem Biol (2014) 0.82

A proteomic primer for the clinician. Proc Am Thorac Soc (2007) 0.77

Fully automated synthesis of (phospho)peptide arrays in microtiter plate wells provides efficient access to protein tyrosine kinase characterization. BMC Immunol (2005) 0.77

Nonradiolabeling assay for WaaP, an essential sugar kinase involved in biosynthesis of core lipopolysaccharide of Pseudomonas aeruginosa. Antimicrob Agents Chemother (2002) 0.76

Rapid Discovery of Functional Small Molecule Ligands against Proteomic Targets through Library-Against-Library Screening. ACS Comb Sci (2016) 0.75

Articles by these authors

(truncated to the top 100)

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol (2001) 6.83

Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother (2001) 4.72

Raised serum levels of tumour necrosis factor in parasitic infections. Lancet (1986) 3.23

Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother (2000) 2.96

Serum leptin and vascular risk factors in obstructive sleep apnea. Chest (2000) 2.53

Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (1995) 2.48

Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother (2001) 2.21

Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol (2000) 2.11

Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells (1991) 1.95

Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan. J Clin Microbiol (2001) 1.88

Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun (1998) 1.84

Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis (1996) 1.77

PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys. Kidney Int (2007) 1.73

Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci U S A (1983) 1.70

Collagen type IX: evidence for covalent linkages to type II collagen in cartilage. FEBS Lett (1987) 1.69

Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjug Chem (2001) 1.65

Control of the initiation of sporulation in Bacillus subtilis by a phosphorelay. Res Microbiol (1992) 1.64

Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother (1995) 1.61

Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect (2000) 1.61

Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection (2001) 1.60

Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun (1998) 1.54

Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection. Clin Exp Dermatol (2009) 1.53

Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum (1995) 1.52

Management outcome and the role of manipulation in slipped capital femoral epiphysis. J Orthop Surg (Hong Kong) (2007) 1.49

Mutational dissociation of the positive and negative regulatory properties of the Spo0A sporulation transcription factor of Bacillus subtilis. Gene (1991) 1.44

A positive feedback loop controls transcription of the spoOF gene, a component of the sporulation phosphorelay in Bacillus subtilis. Mol Microbiol (1993) 1.42

Effect of fluorescently labeling protein probes on kinetics of protein-ligand reactions. Langmuir (2008) 1.40

Selective phosphorylation of a nuclear envelope polypeptide by an endogenous protein kinase. Biochemistry (1979) 1.37

Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother (1997) 1.34

Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res (1987) 1.34

Catalytic growth and characterization of gallium nitride nanowires. J Am Chem Soc (2001) 1.33

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Curr Cancer Drug Targets (2011) 1.33

Electrophoretic analysis of three major nuclear envelope polypeptides. Topological relationship and sequence homology. J Biol Chem (1979) 1.32

Profunda femoris artery pseudoaneurysm presenting with triad of thigh swelling, bleeding and anaemia. Ann Acad Med Singapore (2004) 1.32

A novel high-throughput scanning microscope for label-free detection of protein and small-molecule chemical microarrays. Rev Sci Instrum (2008) 1.32

Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol (2001) 1.28

Arcobacter butzleri bacteremia in a patient with liver cirrhosis. J Formos Med Assoc (2000) 1.26

Collagen of fibrocartilage: a distinctive molecular phenotype in bovine meniscus. FEBS Lett (1983) 1.26

Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J Formos Med Assoc (1996) 1.25

The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Hong Kong Cardiovascular Risk Factor Steering Committee. American Diabetes Association. Diabet Med (2000) 1.24

Two fatal cases of Veillonella bacteremia. Eur J Clin Microbiol Infect Dis (1998) 1.22

Methylobacterium mesophilicum synovitis in an alcoholic. Clin Infect Dis (1997) 1.19

Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan. J Clin Microbiol (2000) 1.16

A growing family of collagens in articular cartilage: identification of 5 genetically distinct types. J Rheumatol (1987) 1.16

A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc Natl Acad Sci U S A (2000) 1.16

Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer (2007) 1.16

Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. Biochem J (1996) 1.15

Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis (1998) 1.15

The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene (2007) 1.14

BMS-182123, a fungal metabolite that inhibits the production of TNF-alpha by macrophages and monocytes. J Antibiot (Tokyo) (1996) 1.13

Applications of topologically segregated bilayer beads in 'one-bead one-compound' combinatorial libraries. J Pept Res (2005) 1.11

Bacteremic necrotizing fasciitis due to Flavobacterium odoratum. Clin Infect Dis (1995) 1.11

Regulation of transcription of the cell division gene ftsA during sporulation of Bacillus subtilis. J Bacteriol (1992) 1.10

Sequence homology analysis of a heterogenous protein population by chemical and enzymic digestion using a two-dimensional sodium dodecyl sulfate-polyacrylamide gel system. Anal Biochem (1980) 1.09

Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist (2001) 1.09

Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob Agents Chemother (2000) 1.09

In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother (1997) 1.08

Snapping syndrome caused by the semitendinosus tendon. A case report. J Bone Joint Surg Am (1989) 1.07

Peptide-encoding for structure determination of nonsequenceable polymers within libraries synthesized and tested on solid-phase supports. Pept Res (1993) 1.07

Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. J Formos Med Assoc (2000) 1.07

Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am J Surg (2000) 1.07

Comparison of the MB/BacT and BACTEC MGIT 960 system for recovery of mycobacteria from clinical specimens. Diagn Microbiol Infect Dis (2000) 1.06

Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells. Infect Immun (1999) 1.05

Pancreatic insulinomas. A 15-year experience. Arch Surg (1997) 1.05

Avulsion of the pectoralis major tendon. Am J Sports Med (1992) 1.04

Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy. J Clin Microbiol (1998) 1.04

Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid. J Biol Chem (1998) 1.04

An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes (1995) 1.04

Comparison of osteotomy healing under external fixation devices with different stiffness characteristics. J Bone Joint Surg Am (1984) 1.04

Recent developments in cartilage research: matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans (2002) 1.04

Group A Streptococcus induces apoptosis in human epithelial cells. Infect Immun (1999) 1.04

Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy. Am J Cardiol (1991) 1.03

Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother (1998) 1.02

Malignant necrotising streptococcal myositis: a rare and fatal condition. J Bone Joint Surg Br (2003) 1.01

An SfiI restriction map of the Bacillus subtilis 168 genome. Gene (1991) 1.01

LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells. Oncogene (2006) 1.01

The importance of early diagnosis in the management of proximal tibiofibular dislocation: a 9- and 5-year follow-up of a bilateral case. Knee (2002) 1.01

Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery (2000) 1.01

High-volume cellular screening for anticancer agents with combinatorial chemical libraries: a new methodology. Mol Divers (1996) 1.00

Fifty cases of primary hyperaldosteronism in Hong Kong Chinese with a high frequency of periodic paralysis. Evaluation of techniques for tumour localisation. Q J Med (1986) 0.99

Cartilage type IX collagen is cross-linked by hydroxypyridinium residues. Biochem Biophys Res Commun (1984) 0.99

Serotypes and biotypes and antibiotic susceptibility of Haemophilus influenzae encountered in a clinical laboratory in Taiwan. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi (1979) 0.98

Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab (1999) 0.98

Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. Eur J Clin Microbiol Infect Dis (2001) 0.98

Sand pits and bucket handles: A case of bilateral traumatic bucket-handle tears of the medial menisci. Arthroscopy (2000) 0.98

Evidence for monomeric and dimeric forms of CD45 associated with a 30-kDa phosphorylated protein. J Biol Chem (1992) 0.98

Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. Eur J Clin Microbiol Infect Dis (2010) 0.98

Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic. Hepatology (2001) 0.98

Identifying substrate motifs of protein kinases by a random library approach. Biochemistry (1994) 0.96

Multiple release of equimolar amounts of peptides from a polymeric carrier using orthogonal linkage-cleavage chemistry. Int J Pept Protein Res (1993) 0.95

Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins. Cancer Res (2001) 0.95

Acute disseminated histoplasmosis complicated with hypercalcaemia. J Infect (1999) 0.95

Chronically painful right thumb with pustules and onycholysis. Diagnosis: acrodermatitis continua of Hallopeau. Clin Exp Dermatol (2007) 0.95

Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care (2000) 0.94

Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism. Clin Chem (1995) 0.94

Purification of a variant-specific surface protein of Giardia lamblia and characterization of its metal-binding properties. J Biol Chem (1995) 0.94

Macromolecular scaffolds for immobilizing small molecule microarrays in label-free detection of protein-ligand interactions on solid support. Anal Chem (2009) 0.93

Collagen structure and cartilage matrix integrity. J Rheumatol Suppl (1995) 0.93

Inhibition of group A streptococcus infection by carboxyfullerene. Antimicrob Agents Chemother (2001) 0.93

Development and characterization of potent and specific peptide inhibitors of p60c-src protein tyrosine kinase using pseudosubstrate-based inhibitor design approach. J Pept Res (2003) 0.93